Advertisement

Ads Placeholder
Loading...

HUTCHMED (China) Limited

HCM•NASDAQ
Healthcare
Drug Manufacturers - Specialty & Generic
$15.42
$0.28(1.85%)
U.S. Market opens in 0h 56m

HUTCHMED (China) Limited (HCM) Stock Overview

Explore HUTCHMED (China) Limited’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap2.8B
P/E Ratio5.85
EPS (TTM)$2.65
ROE0.41%
Fundamental Analysis

AI Price Forecasts

1 Month$10.85
3 Months$14.70
1 Year Target$17.57

HCM Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of HUTCHMED (China) Limited (HCM) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 65.97, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $17.57.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 5.85 and a market capitalization of 2.8B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
1.85%
5-Day Change
10.22%
1-Month Change
14.31%
3-Month Change
12.97%
6-Month Change
-4.16%
Year-to-Date (YTD) Change
12.97%
1-Year Change
1.11%
3-Year Change
23.76%
5-Year Change
-44.75%
All-Time (Max) Change
14.22%

Contact Information

https://www.hutch-med.com
852 2128 1188
Cheung Kong Center, Hong Kong, NaN, NaN

Company Facts

18,110 Employees
IPO DateMar 16, 2016
CountryHK
Actively Trading

Frequently Asked Questions